scanTK is the largest commercial panel of tyrosine kinases that includes a set of 135 both receptor and non-receptor kinases, plus important mutant forms. scanTK provides a comprehensive understanding of compound binding within the tyrosine kinase family and may serve to opportunistically identify unanticipated interactions leading to expanded therapeutic utility of compounds or as advanced starting points for new programs.
Panel Features & Benefits
- The largest panel of receptor and non-receptor tyrosine kinase assays available
- High-quality reproducible data
- Rapid turnaround time
- Dynamic range: can detect compounds with Kds <100 pM to >10 uM
- Flexible – Standard and custom panels
- Detection of multiple inhibitor types (e.g. type I, II & non-ATP competitive)
- Economically priced
